KCNK3: new gene target for pulmonary hypertension? (Q51729363)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24742047 AND SRC:MED&resulttype=core&format=json

14 March 2020

editorial

0 references

title

KCNK3: new gene target for pulmonary hypertension? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24742047 AND SRC:MED&resulttype=core&format=json

14 March 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24742047 AND SRC:MED&resulttype=core&format=json

14 March 2020

Frédéric Perros

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24742047 AND SRC:MED&resulttype=core&format=json

14 March 2020

Fabrice Antigny

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24742047 AND SRC:MED&resulttype=core&format=json

14 March 2020

Marc Humbert

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24742047 AND SRC:MED&resulttype=core&format=json

14 March 2020

1

Barbara Girerd

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24742047 AND SRC:MED&resulttype=core&format=json

14 March 2020

publication date

18 April 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24742047 AND SRC:MED&resulttype=core&format=json

Expert Review of Respiratory Medicine

14 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24742047 AND SRC:MED&resulttype=core&format=json

14 March 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24742047 AND SRC:MED&resulttype=core&format=json

14 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24742047 AND SRC:MED&resulttype=core&format=json

14 March 2020

page(s)

385-387

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24742047 AND SRC:MED&resulttype=core&format=json

Heritable forms of pulmonary arterial hypertension

14 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1586/17476348.2014.909731

Genetics and genomics of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/17476348.2014.909731

A novel channelopathy in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/17476348.2014.909731

Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/17476348.2014.909731

Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/17476348.2014.909731

Longitudinal analysis casts doubt on the presence of genetic anticipation in heritable pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/17476348.2014.909731

Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/17476348.2014.909731

Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/17476348.2014.909731

A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/17476348.2014.909731

Molecular genetic characterization of SMAD signaling molecules in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/17476348.2014.909731

Whole exome sequencing to identify a novel gene (caveolin-1) associated with human pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/17476348.2014.909731

Targeting ion channels for the treatment of autoimmune neuroinflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/17476348.2014.909731

Molecular diagnostics of cardiovascular diseases in sudden unexplained death

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/17476348.2014.909731

Cystic fibrosis: insight into CFTR pathophysiology and pharmacotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/17476348.2014.909731

Combined antisense and pharmacological approaches implicate hTASK as an airway O(2) sensing K( ) channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/17476348.2014.909731

Regulation of the resting potential of rabbit pulmonary artery myocytes by a low threshold, O2-sensing potassium current

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/17476348.2014.909731

Endothelin-1 inhibits background two-pore domain channel TASK-1 in primary human pulmonary artery smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/17476348.2014.909731

TASK1 (K(2P)3.1) K( ) channel inhibition by endothelin-1 is mediated through Rho kinase-dependent phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/17476348.2014.909731

A role for TASK-1 (KCNK3) channels in the chemosensory control of breathing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/17476348.2014.909731

Targeted gene delivery ofBMPR2attenuates pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/17476348.2014.909731

Seeking the right targets: gene therapy advances in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/17476348.2014.909731

Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/17476348.2014.909731

Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/17476348.2014.909731

Abnormal trafficking of endogenously expressed BMPR2 mutant allelic products in patients with heritable pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/17476348.2014.909731

Correction of nonsense BMPR2 and SMAD9 mutations by ataluren in pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/17476348.2014.909731